June 5, 2024

Tata Motors: board has approved to set up a wholly-owned subsidiary for its commercial vehicles business – ‘TML Commercial Vehicles’. The company also approved the merger of Tata Motors Finance with Tata Capital. Kotak Mahindra Bank: received RBI approval to sell a 70% stake in its general insurance subsidiary to Zurich Insurance Company. Torrent Pharma: signed an agreement with the Japanese pharma company ‘Takeda’ to market its acid reflux drug in India. KEC: got orders worth Rs 1,002 cr for civil and defence residential projects Tata Motors: board has approved to set up a wholly-owned subsidiary for its commercial vehicles business – ‘TML Commercial Vehicles’. The company also approved the merger of Tata Motors Finance with Tata Capital. Kotak Mahindra Bank: received RBI approval to sell a 70% stake in its general insurance subsidiary to Zurich Insurance Company. Torrent Pharma: signed an agreement with the Japanese pharma company ‘Takeda’ to market its acid reflux drug in India. KEC: got orders worth Rs 1,002 cr for civil and defence residential projects

by

Tata Motors: board has approved to set up a wholly-owned subsidiary for its commercial vehicles business – ‘TML Commercial Vehicles’. The company also approved the merger of Tata Motors Finance with Tata Capital.

Kotak Mahindra Bank: received RBI approval to sell a 70% stake in its general insurance subsidiary to Zurich Insurance Company.

Torrent Pharma: signed an agreement with the Japanese pharma company ‘Takeda’ to market its acid reflux drug in India.

KEC: got orders worth Rs 1,002 cr for civil and defence residential projects Tata Motors: board has approved to set up a wholly-owned subsidiary for its commercial vehicles business – ‘TML Commercial Vehicles’. The company also approved the merger of Tata Motors Finance with Tata Capital.

Kotak Mahindra Bank: received RBI approval to sell a 70% stake in its general insurance subsidiary to Zurich Insurance Company.

Torrent Pharma: signed an agreement with the Japanese pharma company ‘Takeda’ to market its acid reflux drug in India.

KEC: got orders worth Rs 1,002 cr for civil and defence residential projects

Please follow and like us:
Pin Share

You may also like